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ABSTRACT
The MarR family of transcriptional regulators is an important group of
prokaryotic DNA binding proteins. As the family name implies, multiple antibiotic
resistance, members of the MarR family often regulate the expression of resistance genes
to multiple antibiotics, organic solvents, household disinfectants, detergents, and
oxidative stress agents. Most MarR members act as transcriptional repressors and exist
as homodimers in both free and DNA-bound states. DNA-binding is mediated via a
winged-helix fold and is often relieved by anionic lipophilic ligands.

Deinococcus

radiodurans R1 was found to encode a 181 residue MarR homolog designated HucR
(hypothetical uricase regulator). Biochemical evidence has shown that HucR negatively
regulates expression of uricase and this repression is attenuated by the binding of uric
acid, which is the natural substrate for uricase. In this study we present the crystal
structure of HucR determined to 2.3 Å in the absence of ligand. In addition, a second
crystal form of HucR was determined to 2.9 Å in which three dimers were observed in
the asymmetric unit. Unlike the crystal structure of the MarR homolog, MexR, HucR
does not display large conformational heterogeneity between dimers.

Furthermore,

superpositioning of the HucR dimer with the crystal structure of the OhrR dimer
complexed with DNA suggests that HucR is in a “DNA ready” confirmation in which the
lobes of the DNA binding domains are in a position compatible with DNA binding, with
the exception of minor localized conformational changes needed at the amino termini of
the recognition helices. This is in contrast to what is observed when comparing the
crystal structures of the DNA-bound and unbound OhrR, in which there is a significant
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displacement of the DNA binding domains as a result of conformational changes that
originate at the dimerization interface. The crystal structure of HucR in the absence of
either ligand or DNA suggests that HucR is likely to be fixed in a “DNA ready”
conformation. Thus, the crystal structure of HucR has given new insight into the MarR
family of transcriptional regulators, proving that although these family members share
similar structural folds, their mechanisms for transcriptional regulation are likely very
specialized.
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CHAPTER 1

REVIEW OF LITERATURE
Transcriptional Regulators and the Helix-turn-helix DNA Binding Motif
Transcription is a very intricate cellular process whether it occurs in a prokaryotic
or eukaryotic cell.

Eukaryotic transcription is much more complex and far less

understood compared to that of transcription in prokaryotes. Eukaryotes often require a
multitude of trans-acting factors in addition to RNA polymerase in order to achieve
successful transcript production.

In either case, transcriptional regulators (i.e.

transcription factors or trans-acting proteins) are DNA binding proteins that play a vital
role in modulating gene expression within a cell. In fact, gene expression is primarily
controlled at the level of transcription.

Transcriptional regulators modulate gene

expression by either being activators that up-regulate certain genes or repressors which
down-regulate (i.e. repress) gene expression, or in some cases, they can do both.
Interestingly, E. coli encodes for a higher proportion of transcriptional repressors than
activators with 36% being repressors, 30% being activators, and 20% with dual functions
(1). Moreover, transcription factors can be classified as either local or global regulators
depending on the range of genes that they regulate.
Transcriptional regulators have been placed into one of several groups primarily
based on the structure of their DNA binding motifs. Some of these groups include the
helix-turn-helix (HTH), zinc finger, leucine zipper, helix-loop-helix (HLH), basic
region/leucine zipper (b/zip), basic region/helix-loop-helix/leucine zipper (b/HLH/zip),
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homeodomain, β-sheet, and β-ribbon/hairpin proteins (2,3). NMR and x-ray crystal
structures of prokaryotic transcription factors have revealed three principal DNA binding
motifs: the HTH, winged helix, and the β-ribbon motif (4).
The helix-turn-helix DNA binding motif is the most common DNA binding
structure in bacterial and archaeal transcription factors (1,4). The classical HTH DNA
binding motif was first structurally described in the crystal structures of bacteriophage λ
Cro protein (5,6) and E. coli catabolite activator protein (CAP) (7,8). The canonical HTH
motif consists of two consecutive helices (H2 and H3) that are packed at angles of 120º
relative to each other and are connected by a tight four residue turn in which a glycine is
usually found at the second position (Fig 1).

Apparently the HTH motif alone is

insufficient to undergo independent folding and requires an additional α-helix (H1) to
render this motif as a compact, globular domain (4), which is often collectively referred
to as the DNA binding domain that typically ranges in size from 60 to 90 amino acids (9).
The second α-helix of the HTH motif, H3, is often referred to as the “recognition helix”
and averages nine residues in length. The recognition helix, as its name implies, is
important for making most of the sequence specific contacts with its cognate DNA (10).
This is typically done by insertion of the recognition helix into the major groove of the
DNA, thus making critical base pair contacts that result in sequence specific DNA
binding as illustrated in Fig 1. In fact, each of the four base pairs at the major groove
provide a distinctive hydrogen bonding pattern (like a fingerprint) often referred to as
direct readout, whereas the minor groove does not provide such a distinctive pattern (11).
Nearly all prokaryotic proteins that bind DNA via the HTH motif function as
homodimers and use their two-fold dimer related HTH motifs to bind their cognate
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Figure 1. Canonical helix-turn-helix DNA binding motif complexed with DNA. The
crystal structure of the classical HTH DNA binding motif from E. coli CAP protein
complexed with a 30 bp DNA sequence (8).

palindromic or pseudopalindromic DNA sequence which are also related by 2-fold
symmetry. However, there is not an absolute requirement for dimerization amongst all
HTH DNA binding proteins as demonstrated by the fact that some members of the AraC
family, including E. coli MarA (12) and Rob (13), bind their cognate DNA as monomers.
Both MarA and Rob have two HTH motifs per monomer. However, MarA uses both of
its HTH motifs to make contacts with the major groove, whereas Rob only uses one HTH
motif for major groove recognition and its other HTH motif contributes only DNA
backbone contacts. Thus, it is difficult to speculate on the exact mechanism of proteinDNA interactions simply based on homology modeling in the absence of specific
structural data.
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The Winged Helix DNA Binding Motif
Since the original identification of the HTH DNA binding motif in the Cro and
CAP proteins from bacteriophage λ and E. coli, respectively, structural studies on a
variety of gene regulatory proteins have led to the identification of several variations of
the canonical HTH motif. In fact, variations in this motif are quite common, with HTH
variants occurring in both prokaryotic and eukaryotic gene regulatory proteins. Further
structural disparity within this superfamily came when the co-crystal structure of the
DNA binding domain of eukaryotic hepatocyte nuclear factor-3 (HNF-3) complexed with
its target DNA (14) revealed a significant structural adaptation to the canonical HTH
DNA binding motif. This new DNA binding element was called a “winged HTH motif”
(also referred to as a winged helix motif) and was the basis for a new subclassification of
the canonical HTH DNA binding proteins.
The winged helix fold has been identified in eukaryotes, prokaryotes, archaea, and
viruses.

Interestingly, sequence analysis of the DNA binding domains of archaeal

proteins show that all archaea encode a large number of proteins that contain a HTH
motif. The sequences of these motifs are more closely related to those of prokaryotic
HTH domains than those of eukaryotes. Furthermore, the winged helix motif appears to
be the predominant motif used for DNA binding proteins within the archaeal. (15).
The winged helix domain (Fig 2) is an adaptation of the canonical HTH motif
with a compact α/β structure that has the following topology: H1-S1-H2-T-H3-S2-W1S3-W2, where “H” denotes an α-helix, “S” denotes a β-strand, “T” denotes a turn, and
“W” denotes a loop (16). As the name implies, the most striking feature of this class of
DNA binding proteins is the presence of a structural element referred to as a “wing” that
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is actually a β-hairpin that immediately follows the HTH motif with H2 and H3 of the
winged helix motif corresponding to helices of the canonical HTH motif. The two wings,
W1 and W2, flank the recognition helix, H3, similar to the wings of a butterfly (hence the
name, winged helix motif) (16). Although W1 is always present in members of the
winged-helix family of DNA binding proteins, W2 is sometimes absent, as observed in
the structures of histone H5 (17), E2F, DP2 (18) and MarR (19). Besides the presence of
the wing, winged helix proteins often deviate from the canonical HTH motif by the
length of the turn region that separates H2 and H3. The turn varies among winged helix
proteins but is typically longer than that of the 3-4 residues from the canonical HTH fold.
For example, a 10 residue turn separates H2 and H3 in the crystal structure of OmpR
(20). As a consequence of the extra residues in the turn, the steric hindrance between H2
and H3 is reduced, allowing for a greater variation in the angles between the two helices
(100º to 150º) than that of the canonical HTH (120º) (16,4).
For canonical winged helix DNA binding proteins, the DNA recognition helix
(H3) is primarily responsible for mediating most, but not all, of the sequence specific
contacts. However, the wings seem to differ in their contributions to either sequencespecific DNA recognition or nonspecific protein/DNA stabilization via phosphate
backbone contacts. The NMR structure of MuR from bacteriophage Mu in complex with
its cognate DNA reveals that it uses its wing to make sequence specific contacts as its
wing is bound to the minor groove where it makes direct hydrogen bonds to the
nucleotide bases (22). Moreover, a comparison of the structures of unbound MuR (23)
with that of DNA-bound MuR reveals that the wing undergoes a disorder-to-ordered
transformation and becomes stabilized in the minor groove of the DNA (4). Strikingly,
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H2

Wing

H3

Figure 2. Winged helix DNA binding motif. The winged helix DNA binding motif of
MecI from Staphylococcus aureus in complex with a 24 bp dsDNA with a 1 bp overhang
on either side. Incorporated within this oligonucleotide is the sequence of the blaZ dyad
that repressor MecI binds. The recognition helix, H3, is embedded in the major groove of
the DNA while the wing (yellow β-hairpin) makes only minor groove backbone contacts
(21).
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the co-crystal structure of the RFX1-DNA complex (24) revealed that the wing of RFX1
(W1) makes the majority of its contacts with its cognate DNA by inserting its wing into
the major groove. Furthermore, the recognition helix of RFX1 sits over the minor groove
where it only contributes a single DNA contact via a lysine sidechain and a cytosine.
Thus, although the winged-helix HTH proteins share a common structural motif, there is
significant variation in how this motif interacts with DNA.
Multidrug Resistance and the MarR Family of Transcriptional Regulators
Multidrug resistance (MDR) is a growing worldwide health issue, as various
human pathogens are acquiring the ability to survive ordinarily lethal doses of
structurally diverse drugs (25). The MDR phenotype can arise via several resistance
mechanisms including the action of efflux transporters that actively transport a wide
variety of structurally and chemically dissimilar compounds out of the cell (26). The
crucial role these drug efflux transporter systems play in MDR has been well documented
in eukaryotes as well as prokaryotes (27). Multidrug transporters are generally integral
membrane proteins that are often regulated at the transcriptional level by repressors
and/or activators. Multidrug pumps are usually upregulated in response to the presence
of the natural substrates on which these pumps act, usually as a direct result of the
regulators themselves binding to the same diverse drugs as the substrates for the pumps
that they regulate (28,29,30). Due to the inherent difficulty of crystallizing integral
membrane proteins, there is no structural data to help explain how these transporters
recognize such a vast array of structurally diverse compounds. However, since the
soluble cytosolic regulatory proteins of these transporters also recognize a similar range
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of drugs, structural studies with transcription factors complexed with various drugs might
help elucidate the mechanism by which these pumps recognize and bind multiple drugs.
Although the focus here is on prokaryotic MDR, it is important to mention that
the development of MDR in tumor cells is also a serious concern and a major cause of
failure in anti-tumor chemotherapy (31). Moreover, MDR in tumor cells is usually the
result of an upregulation of the expression of a specific group of broad substrate spectrum
membrane phosphoglycoproteins belonging to the ABC transporter superfamily (31).
Thus, the phenomena of MDR must be addressed at both the prokaryotic and eukaryotic
levels: to help combat emerging human pathogenic bacteria and to facilitate a better
efficiency for tumor cell uptake of anticancer drugs, respectively.
The E. coli AcrAB-TolC multidrug efflux system functions as a tripartite complex
that gives rise to a MDR phenotype which is also referred to as a mar phenotype
(multiple antibiotic resistance) (32) The mar phenotype includes resistance to structurally
diverse antibiotics, organic solvents, household disinfectants, and oxidative stresses
(33,34,35). The mar phenotype in E. coli is directly associated with the expression of the
marRAB operon, specifically expression of the activator protein, MarA, that activates
gene expression of the AcrAB-TolC multidrug efflux pump (35,36,37,38). However, in
the absence of the appropriate stimulus, MarR negatively regulates the marRAB operon
(hence the multi drug efflux system), with repression being alleviated by the presence of
a variety of mostly phenolic-like compounds, most notably salicylate (39,40).
Since the discovery of repressor MarR, several homologs have been identified and
grouped into a common family, the MarR family of transcriptional regulators, named
after the prototypical member MarR (Table 1). Proteins that belong to the MarR family
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often act as environmental sensors by modulating gene expression by a rapid response to
changes in environmental conditions. This is frequently achieved by binding to the same
or oftentimes similar substrates as those for the gene products that they regulate. For
example, the MarR homolog, HucR, is responsible for repression of the uricase gene in
Deinococcus radiodurans. However, in the presence of uric acid which is the substrate
for uricase, HucR-mediated repression of uricase is alleviated (41). Furthermore, most
MarR homologs are repressors of the genes to which they regulate with the exception of
BadR (42), NhhD (43), and ExpG (44) that play roles in activating gene expression, and
SlyA that appears to have dual roles as both a repressor and an activator (45). Members
of the MarR family mediate DNA binding via a winged helix DNA binding motif.
Moreover, MarR homologs exist as homodimers in both free and DNA-bound states, with
DNA binding occurring at either palindromic or pseudopalindromic sequence specific
sites. Finally, several members of the MarR family have been shown to respond to
various anionic lipophilic compounds (usually phenolic-like ligands), usually resulting in
an attenuation of an ability to bind the cognate DNA sequence.
Hypothetical uricase regulator (HucR)
The eubacterial family Deinococcaceae contains some of earth’s most radiationresistant organisms ever described.

Of the several radiation-resistant species of

Deinococcus identified to date (72), the most extensively studied to date is Deinococcus
radiodurans R1, for which the complete genome has been sequenced (73).

D.

radiodurans is a nonpathogenic, gram positive, non-motile, aerobic mesophile best
known for its remarkable ability to withstand both acute and chronic exposures to high
levels of ionizing radiation that often leads to double-strand DNA breaks.
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D.

radiodurans is also highly resistant to other sources of DNA damage including UV
radiation, desiccation, and oxidative stress (72). Moreover, D. radiodurans was found to
encode orthologs to almost all known genes involved in stress responses in bacteria
including pH, desiccation, temperature, phage, starvation, toxin, antibiotic, and oxidative
stresses (72,73).
A gene designated hucR (hypothetical uricase regulator) encoding for a 181
amino acid protein from D. radiodurans was previously identified and characterized and
is believed to play a critical role in the cellular response to oxidative stress (41,63). HucR
shares 29% amino acid sequence identity with prototypical member MarR, thus placing
HucR in the MarR family of transcriptional regulators.
The biochemical characterization of HucR revealed that HucR is a transcriptional
regulatory protein that binds as a homodimer to a single site located within its own
promoter/operator region (hucO). The HucR binding site within hucO contains a
pseudopalindromic sequence of 8-bp half sites separated by 2 bp, thus each HucR subunit
of the dimer binds the same face of the DNA (41). Furthermore, hucO is also located
within the promoter region of a separate gene encoding for uricase that is oriented in the
opposite direction relative to hucR. Thus, this partial overlapping of promoter regions in
which the transcriptional start site of each gene is located within the Pribnow box of the
other provides for a genetically favorable mechanism for the simultaneous co-repression
of both HucR and uricase. The biological substrate for uricase is uric acid, which is
converted to allantoin during purine catabolism (Fig. 3) (74). Interestingly, in vitro
studies have shown that uric acid appears to be the natural ligand for HucR as it binds
HucR with an apparent Kd of 5.9 µM. A concomitant antagonistic effect on HucR-DNA
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binding is observed upon HucR-uric acid binding.

In fact, HucR-DNA complex

formation is reduced by 50% at uric acid concentrations of 260 µM. Furthermore, in vivo
studies have shown that when D. radiodurans was grown in the presence of excess uric
acid, elevated levels of hucR and uricase transcripts were seen as well as increased
uricase activity (41). Taken together, these data strongly support the identification of a
novel regulatory mechanism for maintaining uric acid homeostasis in D. radiodurans in
which HucR-mediated repression of uricase is relieved directly by uric acid.

Uricase
Uric acid

Allantoin

Figure 3. The uric acid degradation reaction catalyzed by the enzyme uricase.

Structural Analysis of the MarR Family
Currently there are four structures of members of the MarR family of
transcriptional regulators including: MarR (19), MexR (68), SlyA-like protein (65), and
OhrR (54). Although this family shares very little amino acid sequence identity, thus far,
they appear to adopt very similar folds. Each structure has contributed its own unique
information about this family of proteins while emphasizing similarities within the
family. All structures have shown that they exist as homodimers with each subunit
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Table 1. Summary of the MarR family of transcriptional regulators.
Organism
Repressor/ Ligands
Activator
FarR Neisseria
Repressor n/a
gonorrhoeae
HpaR Escherichia coli
Repressor 4-hydroxyphenylacetic acid, 3hydroxyphenylacetic
acid, 3,4-hydroxyphenylacetic
acid
HpcR
BadR
OhrR

Repressor
Escherichia coli
Rhodopseudomonas Activator
palustris
Repressor
Xanthomonas
campestris

Footprint
(bp)a
n/a

(bp in
½ sites)f
n/a

Structure

Ref.

n

46

27

9 (4)

n

47

n/a
Benzoate, 4-hydroxybenzoate

n/a
n/a

n/a
n/a

n
n

48, 49
42

tert–butyl hydroperoxide, cumene
hydroperoxide

44

8 (17)

n

50, 51

42b

7 (7)

y

52, 53,
54

8 (0)

n

55

OhrR

Bacillus subtilis

Repressor

tert–butyl hydroperoxide, cumene
hydroperoxide

CinR

Repressor

Cinnamic acid sugar esters

MarR

Butyrivibrio
fibrisolvens
Escherichia coli

Repressor

salicylate, plumbagin, 2,4–
dinitrophenol,
menadione

21

5 (2)

y

39, 56,
19

EmrR

Escherichia coli

Repressor

Nalidixic acid, salicylate caronyl
cyanide m-chlorophenylhydrazone 2,
4–dinitrophenol, ethidium bromide

42

9 (3)

n

57, 58

Table cont
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Organism
PecS

Repressor/ Ligands
Activator
Repressor n/a

Footprint
(bp)a
45

(bp in
½ sites)f
5 (3)

Structure

Ref.

n
59, 60,
Erwinia
61, 62
chrysanthemi
HucR Deinococcus
Repressor uric acid, salicylate
21c
8 (2)
y
41, 63
radiodurans
SlyA Salmonella
Repressor/ n/a
25d
5 (2)
n
45, 64
Activator
typhimurium
SlyA Enterobacter
n/a
n/a
n/a
n/a
y
65
faecalis
HcaR Acinetobacter sp.
Repressor hydroxycinnamoyl-CoA thioesters
n
66
Strain ADP1
MexR Pseudomonas
Repressor n/a
28
5 (5)
y
67, 68
aeruginosa
CbaR Comamonas
Repressor 3-chlorobenzoate, protocatechuate
22
4 (6 or 9) n
69
testosterone BR60
NhhD Rhodococcus
Activator n/a
n/a
n/a
n
43
rhodochrous J1
Hpr
Repressor n/a
n/a
n/a
n
70
Bacillus subtilis
ExpG Sinorhizobium
Activator n/a
21e
6 (3)
n
71, 44
meliloti
a
The smaller DNase I footprint size is indicated when footprint sizes are reported for both strands; footprint size is reported for
sequences with lowest Kd; b Values reported involve cooperative binding to DNA site containing adjacent perfect and
imperfect repeats; c Methidiumpropyl-EDTA-Fe(II) footprint; d Footprint of a predicted high affinity site within a DNA
sequence containing 5 predicted binding sites; e A conserved sequence found in three ExpG binding regions; f Number of base
pairs for each half-site (number of base pairs between half sites in parentheses). This table was modified from Wilkinson et. al,
2006 (86).
Table cont.
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consisting of two independent domains: 1) a globular DNA binding domain displaying a
winged helix motif and 2) a dimerization domain made up of the amino and carboxyl
termini of the protein. Extensive hydrophobic interactions appear to play a crucial role in
subunit association. Furthermore, dimerization requires that the equivalent region of
each dimerization domain

intertwine to form the complete functional dimerization

domain with extensive surface area buried at the interface.
MarR
The first structure for the MarR family was the crystal structure of MarR that was
determined to 2.3 Å resolution in the presence of its ligand, salicylate (19). It revealed a
dimer having a pyramidal shape with overall dimensions of 50 X 55 X 45 Å3
(corresponding to the width, height, and depth relative to the orientation shown in Fig.
4a). The overall topological order of secondary structure in MarR is H1-H2-β1-H3-H4β2-W1-β3-H5-H6 with the winged helix DNA binding domain consisting of β1-H3-H4β2-W1-β3 (amino acids 55-100) and H1, H2, H5, and H6 making up the dimerization
domains. Furthermore, aside from being the first structure to represent this family of
proteins, the MarR structure revealed the binding sites of its ligand, salicylate.
In order to get well diffracting crystals suitable for structure determination, an
extremely high concentration of salicylate (250 mM) was used to co-crystallize MarR in
the presence of the ligand. Two salicylate binding sites per monomer were identified and
called Sal-A and Sal-B (Fig. 4bc). These sites are solvent exposed and are located on
each side of the recognition helix (H3) at the surface of the molecule. Site Sal-A is the
more conserved of the two sites with interactions taking place between residues from
both the wing and the recognition helix. Specifically, the guanidinium side chain of R86
from the wing and the hydroxyl side chain of T72 from the recognition helix make
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hydrogen bonds with the salicylate carboxylate and hydroxyl groups, respectively (Fig.
4c). Further stabilization of site Sal-A comes from the pyrrolidone ring positioned within
3.5 Å of the salicylate ring. Site Sal-B differs in that all interactions with salicylate are
mediated only from the recognition helix. The salicylate carboxylate makes a hydrogen
bond to R77 while the backbone carbonyl of A70 makes a H-bond to the salicylate
hydroxyl group (Fig. 4c).

Furthermore, similar to what is seen for Sal-A, the

hydrophobic side chain from M74 sits just above the salicylate ring, thus stabilizing the
ligand binding pocket via hydrophobic interactions. The proximity of the ligand binding
sites to the winged helix motif suggests a complete interlinkage of DNA and ligand
binding regions.
Although the co-crystal structure of MarR reveals sites Sal-A and Sal-B as
binding sites of salicylate, one must be reminded that MarR has an apparent Kd for
salicylate of 0.5-1 mM (56) and crystallization took place at a markedly high
concentration of salicylate, 250 mM. Furthermore, site Sal-A is involved in the crystal
packing of symmetry-related molecules throughout the crystal lattice. Thus, it is not
possible to conclude whether these sites were an artifact of crystallization or true ligand
binding sites of MarR. However, if these sites are the physiological binding sites for
salicylate, it appears rather straightforward that the mechanism for attenuation of DNA
binding as a result of MarR binding salicylate is steric hindrance. Binding two molecules
of salicylate on each side of the recognition helix should inevitably prevent the
recognition helix from recognizing and binding its cognate DNA sequence. Furthermore,
the confirmation in which MarR crystallized was not in a confirmation suitable for DNA
binding, as the spacing of the recognition helices were not compatible with both
monomers making contacts within the major grooves of the DNA.
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MexR
The second crystal structure for this family was that of MexR determined to 2.1 Å
resolution (68).

MexR is a repressor of the MexAB-OprM operon that encodes a

tripartite multidrug efflux system in Pseudomonas aeruginosa (67).

Furthermore,

mutations in MexR result in the upregulation of the MexAB-OprM operon, thus
conferring MDR, as evidenced by increased resistance to antimicrobials that include βlactams, tetracycline, chloramphenicol, novobiocin, trimethoprim, and sulfonamides (7588).
Repressor MexR was crystallized in the absence of an effector molecule (the
physiological ligand for MexR has yet to be identified). However, fortuitously, in the
absence of an effector molecule, four independent observations of the dimer were made
within the asymmetric unit, thus revealing the plasticity of these proteins as indicated by
the varied conformations for each dimer observed. This is markedly different than what
was observed for MarR in which only a single monomer was observed in the asymmetric
unit, with its dimer mate occurring on the crystallographic 2-fold, thus indicating
relatively minimal flexibility, perhaps as a result of bound ligand.

One particular

conformation found in dimer CD indicates a dimer in an “open” state that can be docked
onto B-form DNA with a “reasonable” good fit, with the largest spacing between the two
recognition helices from each DNA binding domain with a Cα-Cα distance of 29.2 Å
(measured from Arg-73 to Arg-73΄, where prime denotes the other subunit). The spacing
between major grooves in linear B-form DNA is approximately 34 Å. Another MexR
conformation referred to as dimer AB was described as being in the “closed”
conformation, unable to be docked onto DNA, with a short spacing between its
recognition helices of 22.6 Å, far short of the 34 Å needed to reach successive major
16
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H6

H5
H2

H1

β1

H3

β3

SAL-B

β2
H4

C

SAL-A

R86

R86

R77

R77

Sal-A

Sal-A
T72

T72

A70

Sal-B

A70

Sal-B

Figure 4. The crystal structure of MarR and its salicylate binding sites. (A), Ribbon
representation of the MarR dimer with each subunit represented by a different color. (B)
The MarR monomer shown with its recognition helix (orange) and bound salicylate
molecules (magenta) at sites Sal-A and Sal-B. (C) A stereo image of the salicylate
binding sites Sal-A and Sal-B with salicylate molecules (magenta) and contact residues
labeled from one monomer of MarR (19).
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grooves on B-form DNA. Using the DNA binding domains from one monomer to
superpose dimer AB onto dimer CD (Fig. 5), shows just how substantial the difference is
in the “on” state (can bind DNA) compared to the “off” state (can not bind DNA).
Interestingly, the structure of dimer AB shows the C-terminal tail (residues 140-147) of
monomer C positioned between the lobes of the DNA binding domains of dimer AB
resulting in a shortening of the distance between the recognition helices. Thus, it has
been suggested by Lim et al. that the uncharacterized ligand of MexR might mimic that
which is seen in dimer AB, where a ligand binds to MexR between the DNA binding
domains resulting in a neutralization of the electrostatic repulsions of these domains that
usually exist to keep the lobes at optimal spacing to facilitate DNA binding. Again, as in
the MarR crystal structure, it is always possible that this observation is just an artifact of
crystal packing and has no physiological relevance.
OhrR
Very recently, the crystal structure of a MarR family repressor, OhrR, from
Bacillus subtilis was solved in the absence and presence of DNA to resolutions of 2.5 and
2.64 Å, respectively (54). Upon exposure to oxidative stress, a conserved cysteine (C15)
is oxidized to Cys-sulphenic acid which in turn causes a conformational change within
the dimerization domain which is propagated to the DNA binding domain that ultimately
results in the inability of OhrR to bind the ohrA operator, resulting in the derepression
and upregulation of OhrA that encodes an organic hydroperoxide resistance protein
(52,53). In fact, a comparison of the unbound (i.e. reduced OhrR) and DNA bound
structures of OhrR reveals a root mean square deviation (rmsd) of 1.5 Å to 1.7 Å, with
differences primarily confined to the DNA binding domain. Furthermore, in order for the
unbound OhrR structure to assume the conformation of the DNA-bound form, the DNA
18

binding domain of one of the subunits must rotate ~25º relative to the other monomer and
the wing must translocate ~16 Å (as measured from the Cα of E91΄) (Fig. 6).
A 29 bp oligonucleotide containing the ohrA operator sequence was used to
crystallize the OhrR-DNA complex. The recognition helices (H4 and H4’) of the winged
helix motif bind consecutive major grooves of the ohrA operator with the contacts
primarily mediated by the N-termini of these helices (Fig. 7). A total of 44 residues of
the OhrR dimer were found to make 60 contacts with the DNA spanning over 22
nucleotides. Moreover, each subunit of the dimer exhibits almost identical 2-fold related
interactions with the DNA. The crystal structure revealed that the bound DNA is bent ~
10º globally while the major grooves are substantially widened (from 11 Å to 15.5 Å) and
deepened (from 4.0 Å to 6.0 Å) as a result of the insertion of the recognition helix (H4).
The wing from the winged helix DNA binding motif is inserted directly into the minor
groove resulting in localized conformational change of the DNA (overtwisting of a DNA
bp). Wing residues R86, D92, and R94, which are highly conserved throughout the
MarR family, perform the following functions in ohrA binding: R86 makes nonspecific
phosphate backbone contacts, D92 helps coordinate the correct positioning of the
guanidinium group of R94 through side chain electrostatic interactions, and R94 makes
specific contacts with the nucleobase thymine. Finally, DNA binding is further stabilized
by several H-bonds to the phosphate groups along the phosphate backbone of the minor
groove from residues on H2, and most strikingly, H1. Thus, it appears that helix H1 not
only plays a role in dimerization but also contributes to DNA binding.
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CD
AB

Figure 5. Conformational flexibility observed between MexR dimer AB and dimer
CD. Dimers AB (blue) and CD (red) were superposed onto one another relative to their
DNA binding domain from one monomer. The recognition helices are shown in thicker
rendering with cyan corresponding to dimer AB and brown corresponding to dimer CD.
The distances between the recognition helices are measured from the Cα carbons of Arg73 to Arg-73΄. This figure is an adaptation of Fig. 2b from Lim et. al, 2002.
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25º

90º

16Å

Figure 6. Superposition of the reduced and DNA-bound OhrR dimers. A
superposition of the dimers of reduced OhrR (cyan) and DNA-bound OhrR (red) was
done using Cα carbons from one monomer. The curved and straight orange arrows
indicate the rotation angle and wing translocation of the nonsuperposed subunit of the
DNA-bound OhrR relative to the reduced OhrR, respectively. The bottom figure is
identical to the top figure, except for its rotation 90º about the x-axis.
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Wing’
H4’

Wing
H4

Figure 7. The crystal structure of OhrR complexed with DNA. OhrR is shown as a
ribbon representation bound to the 29 bp ohrA operator depicted in stick format. The
recognition helices H4 and H4’ are embedded in the major groove of the DNA with the
wings making phosphate backbone contacts
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CHAPTER 2

THE CRYSTAL STRUCTURE OF HUCR: A MEMBER OF THE
MARR FAMILY OF TRANSCRIPTIONAL REGULATORS
Materials and Methods
Protein Expression and Purification
For expression of native HucR protein, E. coli BL21(DE3) pLysS was
transformed with pSPW1 (41) in which the gene encoding HucR was cloned into the
NdeI/EcoRI sites of the pET-5a expression vector. A single colony was picked from a
plate and incubated overnight in Terrific Broth (TB) containing 100 µg/ml ampicillin and
34 µg/ml chloramphenicol. A 1:100 dilution of this culture was made using fresh TB
containing ampicillin and chloramphenicol and allowed to incubate at 37ºC with constant
shaking (225 rpm) until the A600 reached 0.6 and isopropyl-ß-D-thiogalactopyranoside
(IPTG) was added to a final concentration of 0.1 mM to induce HucR expression. Upon
induction, the temperature was reduced to 20 ºC and the cells were allowed to incubate
for an additional 24 h with continuous shaking. Cells were pelleted by centrifugation at
5,500 X g for 10 min at 4 ºC followed by immediate freezing at -80 ºC. Cells were lysed
with Bugbuster (Novagen) followed by the addition of DNase I and protease inhibitors
pepstatin and leupeptin. Additionally, the cell lysate was sonicated twice in 5 min
intervals to ensure complete cell lysis and to help solubilize HucR protein.

All

subsequent purification procedures were carried out at 4 ºC. The crude lysate was
centrifuged at 11,000 X g for 30 min with the resulting clarified lysate applied to a 10 ml
Affi-Gel Blue Gel (Biorad) column equilibrated with Buffer A (10 mM Hepes, pH 7.0,
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50 mM KCl, and 2 mM ß-Mercaptoethanol) in which HucR was allowed to bind. The
column was then washed with 10 column volumes of Buffer A followed by the elution of
HucR from the column using 2 column volumes of Buffer A supplemented with 1 M
KCl. The eluted HucR was dialyzed in 2L of Buffer A overnight and subsequently
applied to a 15 ml DEAE cellulose column equilibrated with Buffer A and washed with
an additional column volume of Buffer A in which both the flow-through and wash
volumes were collected. HucR does not bind to this column. This flow-through was
immediately added to a 15 ml CM-cellulose column also equilibrated with Buffer A and
washed with one column volume of Buffer A. Again, HucR does not bind under these
conditions and was collected in the flow-through volume. The flow-through was then
applied to a 12 ml hydroxylapatite column equilibrated with Buffer A and the column
was washed with 5 column volumes of Buffer A. HucR was eluted from this column in
batch mode using 2 column volumes of Buffer A supplemented with 1M Potassium
Phosphate. As a final purification step, HucR was then applied to a Superdex 200 size
exclusion column in which the purest fractions of HucR (as determined by SDS-PAGE)
were pooled together and concentrated to 15 mg/mL and flash-frozen in liquid nitrogen
for

storage

at

-80

ºC

(Fig.

8a).

Protein

concentration

was

determined

spectrophotometrically using A280 and a molar extinction coefficient for HucR (ε =
13,940 M-1cm-1).
Selenomethionine-labeled (SeMet) HucR protein was expressed from pSPW1
using E. coli BL21(DE3) pLysS. An overnight culture grown in LB was used to make a
1:100 dilution with fresh M9 media (6g Na2HPO4, 3g KH2PO4, 1g NH4Cl and 0.5 g
NaCl) supplemented with 2 mM MgSO4, 0.1 mM CaCl2, and 4 g/L glycerol. Cells were
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grown until A600 reached 0.5 at which point 100 mg/L of amino acids Thr, Lys, Phe, and
50 mg/L of Leu, Val, and Ile were added to the media to inhibit the methionine
biosynthetic pathway. Cells were grown for an additional 45 min to deplete residual
cellular levels of L-methionine followed by a 0.2 mM IPTG induction, the addition of 50
mg/L selenomethionine, and the reduction in temperature to 24 ºC. Production of SeMetlabeled HucR was allowed to proceed for 24 h before the cells were harvested.
Purification of SeMet HucR was carried out as described above for the native HucR
protein with the exception that Buffer A was supplemented with 10 mM ßMercaptoethanol (Fig. 8b).

A

B

25 kDa
15 kDa

25 kDa
HucR

15 kDa

Figure 8. Purified native and SeMet HucR. Purified protein was analyzed on an SDSPAGE gel to confirm purity. (A) Native HucR. (B) SeMet HucR

Crystallization and Data Collection
HucR crystals were grown by the hanging-drop vapor-diffusion method with 1:1
mixtures of 12 mg/mL of protein and 22 % PEG 3350, 500 mM MgCl2, and 100 mM BisTris, pH 7.0 at 4 ºC. Long rod-like hexagonal shaped crystals appeared after 4 days for
the native HucR and after two weeks for the SeMet-labeled HucR (Fig. 9). Native and
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SeMet crystals belong to the hexagonal space groups P61 (a=b=45.0, c=284.6) and P6122
(a=b=44.9, c=286.4), respectively, and were found to contain two and one molecule
within their asymmetric unit, respectively. A third crystal form of space group P3121
(a=b=77.3, c=266.4) was produced at room temperature in the same conditions
supplemented with 1 mM Pb(NO3)2. The room temperature crystal form, which has three
dimers in the asymmetric unit, was merohedrally twinned with a twin fraction of 0.266 as
determined in CNS (79).

A

B

Figure 9. Crystals of native and selenomethionine-containing HucR. HucR crystals
were obtained using the vapor diffusion method and photographed using a light
polarizing filter. (A) Native HucR. (B) SeMet HucR.

Crystals were flash frozen in liquid nitrogen and diffraction data were collected
with a MarCCD detector (165mm) at the protein crystallography beamline of the Center
for Advanced Microstructures and Devices (CAMD, Louisiana State University) (Fig.
10). All data processing and scaling was carried out with HKL2000 software (80). An
x-ray fluorescence scan was done to verify the presence of selenium in the SeMet crystals
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and to determine the exact wavelengths that correspond to the peak and inflection
wavelengths for selenium (Fig. 11). Data was collected at three wavelengths (peak,
inflection, and remote) for the SeMet HucR crystals to 2.6 Å resolution.

All data

collection statistics are listed in Table 2.
Structure Determination and Refinement
Initial phases (Table 3) were obtained with multiple wavelength anomalous
dispersion (MAD) phasing to 2.8 Å resolution with SeMet data sets. Two of a possible
four selenomethionine residues were apparent in a three-wavelength (peak, inflection,
and remote) anomalous difference Patterson calculated with CNS (Fig. 12) After density
modification which resulted in an overall figure of merit of 0.49, an electron density map
was drawn revealing large solvent channels and continuous regions of electron density
mostly resembling that of alpha helical secondary structure (Fig 13a). To more easily
decipher the electron density, MapMan (81) was used to skeletonize the electron density
(Fig 13bc) and a partial polyalanine model was built into the density using the program O
(82). Side chains were placed by using the selenomethionine sites and large tryptophan
residues to indicate the correct register within the coding sequence. Phase combination
of model and experimental phases was performed to improve map quality until
approximately two-thirds of the model was built. At this point 2Fo-Fc maps at 2.3 Å
resolution were calculated.
Once an Rfree value of 0.43 was obtained, the model derived from the SeMet data
was positioned in the wild-type P61 unit cell for further refinement with non
crystallographic symmetry (NCS) restraint weights of 400. The final 2.3 Å resolution
model

(Rcyst/Rfree = 23.5/29.0) includes 157 of a total of 181 residues: The amino
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Figure 10. Native HucR diffraction image. A diffraction image of the native HucR
taken at the PX beamline of CAMD using a MarCCD detector.
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Selenium Edge
270000

Peak
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255000
240000
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210000
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180000
165000
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Energy (eV)

Figure 11. X-ray fluoresence scan for SeMet crystals. The peak and inflection
wavelengths for selenium in the SeMet crystal were found by doing a fluorescence scan
at the PX beamline of CAMD and determined to be 12658 eV (0.9795 Å) and 12653 eV
(0.9797 Å), respectively.

Table 2. Summary of data collection statistics.
SeMet-MAD
Data set

Peak

Space group
Unit cell
a,b,c (Å)
α,β,γ (°)
Wavelength (Å)
Resolution range (Å)
Unique reflections
Completeness a (%)
Redundancy a
I/σ a
Rsym b (%)

Inflection

Native
Remote

Native

Native

P6122

P61

P3121

44.9, 44.9, 286.4
90, 90, 120
0.9795
0.9798
50-2.65
50-2.65
5659
5714
98.9 (99.8) 98.9 (100)
13.1 (9.2)
10.0 (9.3)
13.9(4.2)
15.9 (5.0)
13.3 (49.0) 11.0 (47.3)

45.0, 45.0, 284.6
90, 90, 120
1.380
50-2.30
14303
98.8 (95.8)
4.4 (3.8)
12.1 (8.1)
7.5 (20.4)

77.3, 77.3, 266.4
90, 90, 120
0.9505
50-2.90
21171
98.6 (99.7)
3.5 (3.5)
8.9 (2.7
12.6 (45.5)

0 .9500
50-2.65
5544
96.4 (99.6)
5.8 (7.7)
9.3 (4.0)
12.4 (47.6)

resolution shell in parentheses
= Σ |Ij - <I>| / Σ<I>, where Ij is the intensity for reflection j and <I> is the mean intensity of the reflection

aHighest
bR
sym
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Table 3. MAD phasing and structure refinement statistics.
SeMet

Native
P61

Native
P3121

Phasing
Resolution range (Å)
500-2.8
Figure of merit
Centrics/acentrics/all
0.68/0.44/0.49
Phasing power
Centrics/acentrics/all
1.55/1.41/1.45
Refinement
Resolution range (Å)
500-2.3
50-2.9
ab
Rcryst/Rfree (%)
23.5/29.0
22.1/30.4
No. of nonhydrogen atoms
Protein/water/chloride
2358/187/2 7088/88/na
rms from ideal geometry
0.007
0.006
Bonds (Å)
1.30
1.20
Angles (º)
2
Average B-factor (Å )
Protein/water/chloride
52/51/41
27.3/19.2/na
Ramachandran plot
87.0
90.9
Res. in most favored regions (%)
10.3
8.3
Res. in add. allowed regions (%)
1.4
0.8
Residues in gen. allowed regions (%)
1.4
0.0
Residues in disallowed region (%)
a
R = Σ||Fo| - |Fc|| / Σ|Fo|, where Fo and Fc are the observed and calculated structure factor
amplitudes.
b
Rfree was calculated by withholding 10% of the total reflections from refinement

Figure 12. Patterson map. The z = 0.5 Harker section of a 3-wavelength anomalous
difference Patterson map from the SeMet datasets.
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A

B

C

Figure 13. Electron density from initial phases. (A) Electron density map contoured
to 1σ after density modification (solvent flipping) in CNS. (B) The skeletonized electron
density from panel A was made using mapman. (C) The final Cα trace of HucR (yellow),
correctly positioned within the skeletonized density seen in panel B.

terminus (residues 1-7), the last two residues on the carboxyl terminus, the wing residues
121-127, and loop residues 27-35 were not visible in the electron density map. In
addition, amino acid residues 25, 36, 88, and 120 have no convincing electron density for
side-chain placement. Final refinement statistics are shown in Table 3 and a
representative 2Fo – Fc electron density map contoured at 1σ is depicted in Figure 14. All
figures were prepared using PYMOL (83), GRASP (84), or O.
The dimer was positioned in the P3121 unit cell with molecular replacement as
implemented in CNS. Six dimers were identified in the asymmetric unit giving a
Matthews coefficient (Vm) of 1.93, within the typical ranges of 1.62-3.53. Refinement
was done in CNS keeping each monomer restrained by NCS weights of 500. The
structure was refined to a resolution of 2.9 Å to give a final Rcryst/Rfree of 22.2/30.5
(Table 3).
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Figure 14. Representative 2Fo – Fc electron density map. A stereo image of a
representative 2Fo – Fc electron density map contoured to 1σ showing the HucR
dimerization interface with each subunit colored in either magenta or green.

Data Deposition
The atomic coordinates and structure factors have been deposited in the Protein
Data Bank under the PDB ID 2FBK.
Results and Discussion
Overall Structure of HucR
The crystal structure of the HucR dimer was determined to 2.3 Å and refined to a
final Rcryst of 23.5% and Rfree of 29.0%. HucR has a “saddle-like” shape with overall
dimensions of 62 Å wide, 42 Å tall and 37 Å deep relative to the orientation shown in Fig
15a. The protein is largely α-helical (55% α-helix, 5% β-strand) with the topology α1α2- α3-β1-α4-α5-β2-β3-α6-α7 (Fig. 15b). The first helix, α1, has no counterpart in any
other MarR family members for which structures have been described. Helices from the
amino and carboxyl termini (α2, α6, and α7) form the dimerization domain, while the
DNA-binding domain is composed of α3, β1, α4, α5, β2, and β3 (Fig. 15b). As predicted,
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the structure reveals that HucR adopts a similar winged-helix fold as that seen in the
structures for MarR, MexR, and OhrR (19,68,54). Consistent with that of other wingedhelix proteins (16), the electrostatic surface potentials of HucR surrounding the
recognition helix (α5) and the wing regions are electropositive, and are likely to interact
with the negatively charged DNA (Fig. 15c,d).

A

B

α1

α7

Dimerization
Domain

α2
α3
α4
α6
β1

DNA Binding
Domain

β3
α5

C

β2

D

Figure 15. Overall structure of HucR. (A) The HucR dimer is shown in a ribbon
drawing with one monomer colored by spectrum from N to C while the other monomer is
depicted in gray. (B) The HucR monomer is shown with each secondary structural
element colored and labeled. The DNA binding domain is encased in a black box (α3, β1,
α4, α5, β2, and β3). The dimerization domain consists of α2, α6, and α7. (C,D) The
electrostatic potential surface map of HucR with positively and negatively charged
regions shown in blue and red, respectively. Figure C is shown in the same orientation
relative to A above, while D is rotated 90° around the x-axis relative to C with the bottom
of C facing outwards in D.

33

The DNA Binding Domain
The DNA binding domain (residues 65 – 133) corresponds to a contiguous stretch
of polypeptide flanked by regions that form the dimerization domain and is comprised of
α3, β1, α4, α5, β2, and β3 (Fig. 15b). The winged-helix motif characteristic of the MarR
family is an adaptation of the classical helix-turn-helix DNA binding motif and in HucR
corresponds to short α-helices, α4 and α5, that pack at approximately 110°, followed by
two anti-parallel β-strands (β2 and β3) that form a β-hairpin referred to as the “wing.”
Helix α3 appears to serve as a scaffold-like structure for this domain as it mediates the
majority of interactions within its own domain and those with the dimerization domain as
well. The crystal structure reveals that the DNA binding domains of HucR are completely
independent of one another, in contrast to what is observed for MarR in which a salt
bridge links the two domains together.
The 17 residue β-hairpin “wings” of HucR jut out from the globular portion of the
DNA binding domains to provide an exceptionally electropositive surface (Fig. 15c,d):
six of the 17 amino acids are arginines (118, 119, 123, 125, 126, and 130). Previous
biochemical evidence has shown that R118A HucR binds DNA with an affinity reduced
6-fold compared to that for wild type HucR (63). Moreover, the R118A mutant had no
effect on sequence specificity of DNA binding, thus it is tempting to speculate that the
wing is important for maintaining non-specific HucR/DNA interactions similar to what is
observed in other canonical winged helix proteins (16).
Most winged helix proteins make sequence specific contacts to their respective
DNA targets via the recognition helix that immediately precedes the wing motif (16). In
the crystal structure of HucR, helix α5 (residues 101-113) is designated the recognition
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helix, and is unusual in the fact that its amino terminus is a very short 3-residue 3-10
helix which turns into a typical 8-residue right-handed α-helix. The electrostatic potential
map shows that HucR’s recognition helix is electropositive on both sides, a common
feature for many winged-helix DNA binding proteins (Fig. 15c,d).

In the crystal

structure, the recognition helix is anchored to the central scaffold helix of the DNA
binding domain (α3) via a salt bridge between Arg-106 and Asp-73 and side chain
hydrogen bonding between Arg-109 and Asn-68. In addition, Lys-113 makes a hydrogen
bond to the main chain carbonyl group of Gly-66, located on a turn between helices α2
and α3. Furthermore, this Lys-113/Gly-66 interaction is functionally identical to side
chain- main chain H-bonds in MarR (Lys-81/Asp-37) and MexR (Arg-78/Asp-34) and
OhrR (Gln-81/Asn-37). Such an interaction may be necessary to anchor the C-terminal
end of the recognition helix in a position suitable for DNA binding.
A structure-based sequence alignment of HucR, MarR, MexR, and OhrR is
presented in Figure 16. Hydrophobic residues conserved throughout the DNA binding
domain appear to be important in stabilization of the overall fold of the DNA binding
domain. In fact, the DNA binding domain has about twice as many invariant and/or
highly conserved residues compared to the dimerization domain (Fig. 16), while it
represents just one third of the protein. The bulk of the conserved amino acids are located
in the hydrophobic core and include Leu-67, -74, -75, -78, -87, -92, -110, -115 -132 and
Ile-107, -116,-130 (Fig. 17).

Another invariant residue from the MarR family of

transcriptional regulators is Thr-133 which is located at the proximal end of the wing
between β3 and helix α6. This residue appears to clamp the wing in place by making two
hydrogen bonding interactions: its side chain hydroxyl group makes an H-bond (2.7 Å)
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with the backbone carbonyl of Gly-114 and the main chain nitrogen participates in an Hbond (2.9 Å) with the backbone carbonyl of Leu-115. The length of the wing is further
stabilized by typical β-sheet interactions and an additional salt bridge between Arg-131
and Glu-117. There is insufficient electron density in the map to model the residues that
comprise the distal wing (121-127), most likely as a consequence of a high degree of
flexibility in this region. Such mobility is common in winged helix proteins, especially
when the wing is not in a complex with its target DNA (68,85).

Figure 16. Structure based sequence alignment between HucR, MarR, MexR, and
OhrR. Secondary structural elements and residue numbering corresponds to that of
HucR. Residues shown in red font have no interpretable electron density in the structure
of HucR and were not used in the superpositioning of the structures. Regions of amino
acid conservation corresponding to invariant and similar are shaded in cyan and yellow,
respectively. The DNA binding domain is encased within the black box.
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Wing

Recognition
Helix

Figure 17. Hydrophobic interactions of the DNA binding domain. The DNA binding
domain of HucR forms a compact globular domain with a hydrophobic core; many of the
core residues are highly conserved within the MarR family, including Leu-67, -74, -75,
-78, -87, -92, -110, -115 -132 and Ile-107, -116,-130.
The Dimerization Domain
Helices α2, α6, α7, α2´, α6΄, and α7΄ (where prime denotes the other subunit) form
the intertwined helical bundle that constitutes the dimerization domain. Helices α2 and
α2΄ are oriented in an anti-parallel fashion to form the scaffold of the dimerization
interface, while helices α6 and α7 straddle helix α2΄ and α6΄ and α7΄ straddle α2. As a
consequence of interdigitation of the helices, approximately 6300 Å2 of surface area is
buried at the dimerization interface. At the center of this packing located along the twofold rotation axis of the dimer is a π-stacking interaction between the imidazole rings of
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His-51 and His-51΄ in which the rings are parallel and separated by a distance of 3.6 Å
(Fig. 14). Helices α2 and α2΄ also interact through hydrophobic interactions that include
Leu-54/Leu-44΄ and Leu-50/Leu-47΄, and there two well-ordered pockets of water
molecules located on either side of the stacked His-51/His-51΄ rings. The C-terminal
helix α7 forms a coiled coil leucine zipper-like structure with extensive hydrophobic
interactions with α2΄, while α6 and α2΄ make only limited hydrophobic contacts.
Additional interactions that contribute to dimer stabilization are the intermolecular salt
bridges Arg-172/Glu-162΄ (α7/α7΄) and Arg-17/Glu-167΄ (α1/α7΄). An intramolecular
salt bridge between Arg-153 and Glu-57 stabilizes an interaction between the amino and
carboxyl terminal helices that flank the DNA binding domain.
Interestingly, the crystal structure of HucR and the structure-based alignment
(Fig. 16) reveal two conserved residues that might play a critical role in dimerization for
members of the MarR family. Residues Leu-166, which is strictly conserved in the MarR
superfamily, and Leu-166΄ of HucR make contact at the two-fold rotation axis. They,
along with other hydrophobic residues, collectively participate in the formation of the
compact core of the dimerization domain, thus stabilizing helices α7, α7΄, α2, and α2΄ at
this site. The MarR, MexR, and OhrR equivalents (Leu-139, Leu-131, and Leu-132,
respectively) of Leu-166 in those structures participate in similar van der Waals
interactions. Leu-158 from HucR, also conserved in MexR and MarR, serves to anchor a
turn region located between helices α6 and α7 to the carboxyl terminal helix α7΄ of the
opposing monomer. Residues corresponding to Leu-158 in both MarR and MexR (Leu127 and Leu-123, respectively) perform a similar structural role in those proteins and are
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likely to have a similar function in all MarR family members given that this residue is
highly conserved throughout the superfamily.
As referred to above, near the midpoint of the 40 Å long α2 and α2΄ helices that
provide the framework for the dimerization domain, the imidazole rings of His-51 and
His-51΄ are stacked and separated by a distance of 3.6 Å (Figs. 14 and 18) At pH 7.0, the
pH at which the crystals were obtained, the imidazoles would be expected to be
deprotonated and thus such an interaction is permissible. However, this configuration of
His-side chains suggests that the dimer interface can serve as a pH sensor, and that a
transient drop in pH could lead to a conformational change induced by the repulsion of
like charges. Conformational changes at the dimer interface of MarR family members
result in repositioning of the DNA binding domains. Thus DNA binding is abrogated if
the domains are repositioned such that spacing between the recognition helices of
winged-helix motifs is not compatible with the distance between the major groves of the
cognate operator. In the MexR structure, determined in the absence of ligand or DNA,
four independent dimers were observed and the relative orientations of the monomers
within each dimer differ as a result of deviations at the dimerization interfaces, and
structural heterogeneity in the monomer itself (68). The structure of the reduced form of
the oxidative stress sensor OhrR in the absence and presence of DNA similarly revealed
differences at the dimer interface (54). Furthermore, the authors propose that oxidation of
the conserved Cys, located at the amino terminus of the α-helix of OhrR that corresponds
to α2 in HucR, induces a conformational change at the dimer interface and thus abrogates
DNA binding.
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Figure 18. Imidazole ring stacking at the HucR dimerization interface. (A) A global
view of the HucR dimer shown as a Cα trace with helices α2 and α2΄ shown as a ribbon
drawing (gold) and His-51 and His-51΄ imidazoles shown in stick format (green and
blue). (B) A close-up look at the imidazole ring stacking interactions.
HucR-DNA Interactions
In addition to the 2.3 Å structure of HucR, a second crystal form (space group
P3121) was solved in the absence of ligand to 2.9 Å with three dimers found in the
asymmetric unit. Superpositioning of all three dimers from the second crystal form with
the original P61 dimer using 314 Cα carbons revealed that there is very little flexibility
between each of the observed HucR dimers as indicated by a similar positioning of the
DNA binding lobes from each monomer relative to the other (Fig. 19). In fact the
variation in r.m.s. deviation between all four dimers was between 0.6 Å and 1.4 Å. This
is in stark contrast to what is seen in the crystal structure of MexR in which there are
significant differences in the positioning of the DNA binding domains, specifically for
dimer AB compared to dimer CD (Fig. 5) Furthermore, the authors suggest that it is this
flexibility that is likely responsible for determining whether MexR can or cannot bind its
cognate DNA as a direct result of the positioning of the two DNA binding domains
relative to one another (68). Additionally, the observation that MarR was unable to
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crystallize in the absence of its ligand supports the possibility that it too has inherent
conformational flexibility. Thus, the HucR dimer appears to lack the conformational
flexibility that is observed in MexR and MarR and likely stays in a more fixed
confirmation even in the absence of its ligand (uric acid) or its cognate DNA.

Figure 19. Superposition of HucR dimers. The three dimers from the P3121 space
group crystal form and the one dimer from the P61 crystal form were superposed using
314 Cα carbons to illustrate the lack of conformational heterogeneity between the four
HucR dimers. The Cα traces for the dimers are shown (the P61 dimer is green).
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The crystal structure of HucR also reveals that the lobes of the DNA binding
domains are positioned with a spacing compatible with DNA binding. Superposition of
the HucR dimer on the structure of the OhrR DNA-bound dimer puts the recognition
helices from each subunit directly on top of one another, suggesting that no major
reorientation of the domain interface is necessary to position the DNA binding domains
to make contacts in the major grooves of its operator, hucO (Fig. 20a,b). Thus, due to the
lack of conformational flexibility as noted above, it is our belief that HucR remains fixed
in a “DNA ready” confirmation in which the lobes of the DNA binding domains are in a
position ready to bind DNA. However, a localized conformational change is needed in
residues 99-104 consisting of the loop between helices α4 and α5 (i.e. the turn of the
HTH motif) and the N-terminal end of α5 (the recognition helix) in order to become fully
compatable with DNA binding, as that defined by the OhrR-DNA structure (fig 20a,b).
Furthermore, the N-termini of the recognition helices adopt a 3-10 helix secondary
structure at the position of the largest degree of steric clashing between HucR and DNA
(most notably Pro-101 and Ser-102), it is possible that DNA binding facilitates the
reorientation of this region of the recognition helix to allow for proper major groove
binding interactions. To further support this hypothesis, figure 21 shows a distribution of
the thermal B-factors for HucR in which relatively high values (as compared to the other
regions of HucR) are found at the N-termini of the recognition helices. High B-factors
generally indicate increased thermal motion or regions of disorder as a consequence of
increased motion. Thus in contrast to what is observed for OhrR in the absence of DNA,
the dimer interface of HucR in the absence of DNA is compatible with DNA
binding.
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A

B

Figure 20. Superposition of the HucR dimer on the OhrR-DNA bound dimer and
DNA. (A) Superposition of HucR (red) on the OhrR-DNA bound structure (blue) with
heavy black circles indicating similar positioning of the recognition helices and heavy
green circles representing the N-terminal regions of the recognition helices of HucR that
require minor localized conformational changes to facilitate DNA binding. (B) The
DNA binding domain of HucR (red, recognition helix yellow) modeled onto DNA
according to the superposition in (A). Positions at which HucR clashes with the DNA are
highlighted with white circles.
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Figure 21. Illustration of B-factors for HucR. The B-factor distribution of the Cα
carbons in HucR is shown so that B-factors are color coded from highest values to lowest
values (i.e. red→ orange→ yellow→ green→ cyan → blue). Heavy black circles located
at the N-terminal regions of the recognition helices correspond to regions that have high
B-factors and would have to undergo minor localized conformational change to facilitate
DNA binding.
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CHAPTER 3

CONCLUDING REMARKS

The crystal structure of HucR has given new insight into the MarR family of
transcriptional regulators as well as emphasized reoccurring themes throughout this
family. The overall structure of HucR is largely alpha helical having structural topology
very similar to the structures of other MarR family members, with the exception of an
additional α-helix at the amino terminus. The function of this helix is unknown and
awaits future investigation, however, the crystal structure suggests that it might function
to further stabilize the primary dimerization helix, α2, as demonstrated by several
hydrophobic interactions.

The HucR dimer has a “saddle-like” shape in which the

subunits are extensively intertwined which results in approximately 6300 Å2 of surface
are buried at the dimerization interface with most of these contacts mediated primarily by
van der Waals interactions.
HucR has two domains: 1) a dimerization domain comprised of α-helices from
both the amino and carboxyl termini and 2) a globular DNA binding domain composed of
residues encoded within the interior of the polypeptide. As predicted, HucR adopts a
similar winged helix motif as seen for other MarR homologs for which structures have
been described. Furthermore, the electrostatic surface potentials of HucR indicate that
the regions around the recognition helices and the wing are highly electropositive, and are
likely to provide a favorable mechanism for electrostatic interaction with the negatively
charged DNA.
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A second crystal form (P3121) of HucR was solved containing three dimers in the
asymmetric unit. Comparison of these three dimers with the original dimer of the first
crystal form (P61) reveals that there is very little conformational heterogeneity among the
four dimers: the r.m.s. deviation range is from 0.6 Å to 1.4 Å. This is in contrast to
what was described for the structure of MexR, in which significant variations in the
MexR dimers were observed. Furthermore, a superposition of the HucR dimer with the
structure of the DNA-bound OhrR, reveals that HucR is in a “DNA ready” confirmation
in which the lobes of the DNA binding domains are in a position ready to bind DNA with
the exception of some localized conformational changes needed at the amino termini of
the recognition helices. Interestingly, a comparison of the OhrR DNA-bound structure
with the nonbound OhrR reveals that significant reorientation of the DNA binding
domains occurs upon DNA binding. Since HucR is in a DNA ready conformation in the
absence of DNA, we suggest that HucR might remain fixed in this state at all times, even
in the absence of DNA or ligand. The fact that four independent observations of the
HucR dimer show that HucR maintains this state is further evidence that supports that
HucR remains fixed in a DNA ready confirmation. If this is true, how does HucR lose its
ability to bind DNA, as demonstrated by the presence of uric acid. One possibility is that
the ligand binds to a region of the winged helix DNA binding motif and actively blocks
DNA interactions via steric hindrance, similar to what is believed to occur with MarR
and its ligand, salicylate.

A second possibility, is that urate binding induces a

conformational change resulting in a displacement of the DNA binding domain in a
conformation not compatible with DNA binding.

The fact that HucR crystals

immediately crack when soaked with uric acid indicate that significant conformational
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change likely occurs upon ligand binding. The site for which uric acid binds has yet to be
determined. Interestingly, a third possibility is that the stacked imidazole rings from His51 and His-51΄ might act as a pH sensor and should there be a transient drop in pH so that
the rings become protonated, the resulting repulsion of like charges could lead to a
localized conformational change that would be propagated out to the lobes of the DNA
binding domains placing them in a position not compatible with DNA binding. This
might be advantageous to the cell if uric acid solubility is compromised during transient
drops in pH which would result in an upregulation of cellular uricase levels to ensure uric
acid is degraded before it precipitates within the cell. Interestingly, a substitution of
phenylalanine for histidine at this position would eliminate the possibility of protonation
while still allow the pi-stacking interactions to take place, thus providing a nice system to
test this hypothesis of pH-mediated abrogation of DNA binding.
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